NYSE:AET - Aetna Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$212.70
+0.30 (1.20%)
Get New Aetna Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AET and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AET

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aetna in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $212.70.
N/A
The current consensus among 0 investment analysts is to n/a stock in Aetna. This rating has held steady since October 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/31/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$207.00 ➝ $205.00Low
i
10/31/2018CitigroupBoost Price TargetNeutral ➝ Neutral$202.00 ➝ $206.00Low
i
10/30/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$212.00 ➝ $206.00Low
i
10/30/2018Cantor FitzgeraldReiterated RatingHold$204.00Low
i
Rating by S. Halper at Cantor Fitzgerald
10/22/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$202.00 ➝ $207.00Low
i
8/22/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$202.00Low
i
Rating by S. Halper at Cantor Fitzgerald
8/2/2018Cantor FitzgeraldReiterated RatingBuy$202.00Low
i
Rating by S. Halper at Cantor Fitzgerald
5/14/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$208.00 ➝ $194.00Low
i
5/1/2018Cantor FitzgeraldUpgradeNeutral ➝ OverweightMedium
i
Rating by S. Halper at Cantor Fitzgerald
1/31/2018Jefferies Financial GroupReiterated RatingHold$205.00Low
i
1/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$200.00 ➝ $208.00Medium
i
1/31/2018CitigroupDowngradeBuy ➝ Neutral$187.89 ➝ $212.00Low
i
1/30/2018CowenReiterated RatingBuy$212.00Low
i
1/30/2018Piper Jaffray CompaniesReiterated RatingBuy$212.00Low
i
1/22/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$195.00 ➝ $212.00Low
i
1/3/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$136.00Low
i
12/20/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$179.00Low
i
12/6/2017Credit Suisse GroupReiterated RatingNeutral$174.00 ➝ $195.00Low
i
12/6/2017ArgusDowngradeBuy ➝ Hold$185.00Low
i
12/4/2017Wells Fargo & CompanyReiterated RatingOutperform$200.00 ➝ $208.00High
i
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$187.00N/A
i
11/3/2017Raymond JamesUpgradeMarket Perform ➝ Outperform$200.00N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$174.00N/A
i
11/2/2017CitigroupBoost Price TargetBuy$183.00 ➝ $197.00N/A
i
11/1/2017Jefferies Financial GroupBoost Price TargetHold$165.00 ➝ $185.00N/A
i
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 ➝ $200.00N/A
i
10/26/2017Cantor FitzgeraldDowngradeOverweight ➝ NeutralN/A
i
10/23/2017Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$175.00N/A
i
Rating by S. Halper at Cantor Fitzgerald
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$175.00N/A
i
10/13/2017Jefferies Financial GroupBoost Price TargetHold$163.00 ➝ $165.00N/A
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
9/12/2017ArgusReiterated RatingBuy$165.00 ➝ $185.00Low
i
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 ➝ $179.00Low
i
8/9/2017Cantor FitzgeraldReiterated RatingOverweight$150.00 ➝ $175.00Low
i
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$157.00 ➝ $163.00Low
i
8/4/2017Jefferies Financial GroupReiterated RatingHold$157.00 ➝ $163.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
8/4/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$162.00 ➝ $171.00Medium
i
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$144.00 ➝ $157.00Low
i
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 ➝ $165.00Low
i
6/28/2017CitigroupInitiated CoverageBuy ➝ Buy$180.00Low
i
6/9/2017Royal Bank of CanadaBoost Price TargetOutperform$147.00 ➝ $162.00Low
i
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$162.00Medium
i
5/30/2017ArgusReiterated RatingBuy$145.00 ➝ $165.00Low
i
5/27/2017CowenSet Price TargetBuy$145.00 ➝ $170.00N/A
i
Rating by Christine Arnold at Cowen Inc
5/17/2017Credit Suisse GroupReiterated RatingBuy$155.00Low
i
5/17/2017UBS GroupReiterated RatingBuy$147.00 ➝ $160.00N/A
i
5/17/2017Bank of AmericaReiterated RatingBuy$160.00 ➝ $168.00Medium
i
5/16/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$150.00 ➝ $158.00Low
i
5/15/2017BarclaysReiterated RatingOverweight$162.00Low
i
5/12/2017Cantor FitzgeraldReiterated RatingBuy$150.00Low
i
5/11/2017Cleveland ResearchUpgradeNeutral ➝ BuyLow
i
5/3/2017Jefferies Financial GroupReiterated RatingHold$133.00 ➝ $140.00Low
i
Rating by Sean Dodge at Jefferies Financial Group Inc.
5/3/2017Stifel NicolausReiterated RatingBuy$130.00 ➝ $150.00Low
i
5/3/2017Cantor FitzgeraldReiterated RatingOverweight$140.00 ➝ $150.00Low
i
4/24/2017Royal Bank of CanadaReiterated RatingBuy$145.00Low
i
4/13/2017Jefferies Financial GroupReiterated RatingHold$133.00Low
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$135.00Low
i
4/3/2017CIBCReiterated RatingOutperformLow
i
3/31/2017OppenheimerReiterated RatingOutperformLow
i
2/21/2017Cantor FitzgeraldReiterated RatingOverweight$140.00N/A
i
2/14/2017Cantor FitzgeraldReiterated RatingOverweightN/A
i
2/7/2017Cantor FitzgeraldInitiated CoverageOverweightN/A
i
2/6/2017Cantor FitzgeraldReiterated RatingBuy$140.00N/A
i
2/1/2017Jefferies Financial GroupBoost Price Target$133.00N/A
i
1/31/2017Sanford C. BernsteinDowngradeOutperform ➝ Market PerformN/A
i
1/24/2017SVB LeerinkDowngradeOutperform ➝ Market Perform$135.00N/A
i
Rating by A. Gupte at SVB Leerink LLC
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/A
i
1/3/2017Royal Bank of CanadaReiterated RatingBuy$145.00N/A
i
12/28/2016ArgusReiterated RatingBuy$130.00 ➝ $145.00N/A
i
12/23/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
12/16/2016Jefferies Financial GroupReiterated RatingHold$130.00N/A
i
11/14/2016Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$132.00N/A
i
11/11/2016Credit Suisse GroupUpgradeNeutral ➝ Outperform$120.00 ➝ $125.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
11/7/2016BarclaysReiterated RatingBuy$142.00N/A
i
9/22/2016Evercore ISIInitiated CoverageBuy$128.00N/A
i
9/13/2016Credit Suisse GroupReiterated RatingHold$120.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
9/6/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
8/31/2016UBS GroupReiterated RatingBuyN/A
i
Rating by a.j. rice at UBS Group AG
8/30/2016Credit Suisse GroupReiterated RatingHold$120.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
8/24/2016SVB LeerinkReiterated RatingOutperformN/A
i
8/23/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
8/17/2016(FBRC)Reiterated RatingHoldN/A
i
8/17/2016Credit Suisse GroupReiterated RatingHold$120.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
8/16/2016SVB LeerinkReiterated RatingOutperformN/A
i
8/4/2016(FBRC)Reiterated RatingHold$135.00N/A
i
8/4/2016SVB LeerinkReiterated RatingBuy$135.00N/A
i
8/3/2016Credit Suisse GroupReiterated RatingHold$120.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
7/21/2016Wolfe ResearchDowngradeOutperform ➝ Peer PerformN/A
i
7/10/2016Credit Suisse GroupReiterated RatingNeutral ➝ HoldN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/29/2016Credit Suisse GroupReiterated RatingHold$120.00N/A
i
6/28/2016Wolfe ResearchInitiated CoverageOutperform$154.00N/A
i
6/21/2016SVB LeerinkReiterated RatingOutperformN/A
i
6/16/2016Sanford C. BernsteinInitiated CoverageOutperform$142.00N/A
i
6/14/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Andrew Schenker at Morgan Stanley
6/2/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Peter Costa at Wells Fargo & Company
5/16/2016Sterne Agee CRTReiterated RatingBuyN/A
i
Rating by B. Wright at Sterne Agee CRT
4/30/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Andrew Schenker at Morgan Stanley
4/29/2016(FBRC)Reiterated RatingHold$135.00N/A
i
4/29/2016Royal Bank of CanadaBoost Price TargetOutperform$140.00 ➝ $144.00N/A
i
(Data available from 4/22/2016 forward)
Aetna logo
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Read More

Today's Range

Now: $212.70
$211.79
$213.36

50 Day Range

MA: $212.70
$212.70
$212.70

52 Week Range

Now: $212.70
$166.88
$213.36

Volume

11,862,705 shs

Average Volume

3,688,920 shs

Market Capitalization

$69.64 billion

P/E Ratio

21.57

Dividend Yield

0.94%

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Aetna?

The following Wall Street sell-side analysts have issued research reports on Aetna in the last twelve months:
View the latest analyst ratings for AET.

What is the current price target for Aetna?

0 Wall Street analysts have set twelve-month price targets for Aetna in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aetna in the next year.
View the latest price targets for AET.

What is the current consensus analyst rating for Aetna?

Aetna currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AET.

What other companies compete with Aetna?

Other companies that are similar to Aetna include UnitedHealth Group, Anthem, Cigna, Humana, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Aetna's investor relations team?

Aetna's physical mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company's listed phone number is 860-273-0123 and its investor relations email address is [email protected] The official website for Aetna is www.aetna.com.